Literature DB >> 7639340

Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy.

M L Schmidt1, K A Robinson, V M Lee, J Q Trojanowski.   

Abstract

Amyloid beta peptides (A beta) are deposited in the brains of Alzheimer's disease (AD) and elderly Down's syndrome (DS) patients in a variety of amyloid plaques. Among these are classical plaques composed of a spherical core and corona. Analyzing AD tissue sections single and double stained with anti-A beta antibodies and thioflavin S (thioS) by bright field, fluorescence, and confocal microscopy revealed that spherical plaque cores consist of a thioS-positive center and an anti-A beta antibody immunoreactive rim. This indicates that there is a fibrillar form of amyloid that is thioS positive but not immunoreactive with anti-A beta antibodies. In contrast, classical plaques in DS patients have irregular cores that are thioS positive as well as anti-A beta immunoreactive. In addition, a subset of plaques in both DS and AD patients have a distinct "fibrous" appearance when stained with thioS, but are amorphous when immunostained. These findings suggest that anti-A beta antibodies and thioS stain similar; as well as different forms of fibrillar amyloid. A beta may become thioS positive by interacting with one or more of its known molecular chaperons, and this may be important for the pathogenesis of AD, given that thioS-positive A beta deposits are associated with neuritic and synaptic damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7639340      PMCID: PMC1869826     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

1.  An analysis of the morphology of senile plaques in Down's syndrome patients of different ages using immunocytochemical and lectin histochemical techniques.

Authors:  D M Mann; A Brown; D Prinja; C A Davies; M Landon; C L Masters; K Beyreuthers
Journal:  Neuropathol Appl Neurobiol       Date:  1989 Jul-Aug       Impact factor: 8.090

2.  Early senile plaques in Down's syndrome brains show a close relationship with cell bodies of neurons.

Authors:  D Allsop; S I Haga; C Haga; S I Ikeda; D M Mann; T Ishii
Journal:  Neuropathol Appl Neurobiol       Date:  1989 Nov-Dec       Impact factor: 8.090

3.  Ultrastructural studies of the cells forming amyloid fibers in classical plaques.

Authors:  H M Wisniewski; J Wegiel; K C Wang; M Kujawa; B Lach
Journal:  Can J Neurol Sci       Date:  1989-11       Impact factor: 2.104

4.  Alzheimer patients and Down patients: cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques.

Authors:  L Verga; B Frangione; F Tagliavini; G Giaccone; A Migheli; O Bugiani
Journal:  Neurosci Lett       Date:  1989-11-06       Impact factor: 3.046

Review 5.  Confocal microscopy: an overview.

Authors:  H Shuman; J M Murray; C DiLullo
Journal:  Biotechniques       Date:  1989-02       Impact factor: 1.993

6.  Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.

Authors:  P Cras; M Kawai; S Siedlak; P Mulvihill; P Gambetti; D Lowery; P Gonzalez-DeWhitt; B Greenberg; G Perry
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

7.  A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis.

Authors:  S G Greenberg; P Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

8.  Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques.

Authors:  H Arai; V M Lee; L Otvos; B D Greenberg; D E Lowery; S K Sharma; M L Schmidt; J Q Trojanowski
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

9.  About the presence of paired helical filaments in dystrophic neurites participating in the plaque formation.

Authors:  M Barcikowska; H M Wisniewski; C Bancher; I Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

10.  Formation of amyloid-like fibrils in COS cells overexpressing part of the Alzheimer amyloid protein precursor.

Authors:  K Maruyama; K Terakado; M Usami; K Yoshikawa
Journal:  Nature       Date:  1990-10-11       Impact factor: 49.962

View more
  25 in total

1.  Imaging linear birefringence and dichroism in cerebral amyloid pathologies.

Authors:  Lee-Way Jin; Kacey A Claborn; Miki Kurimoto; Morten A Geday; Izumi Maezawa; Faranak Sohraby; Marcus Estrada; Werner Kaminksy; Bart Kahr
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

Review 2.  Neuropathological correlates of amyloid PET imaging in Down syndrome.

Authors:  Eric E Abrahamson; Elizabeth Head; Ira T Lott; Benjamin L Handen; Elliott J Mufson; Bradley T Christian; William E Klunk; Milos D Ikonomovic
Journal:  Dev Neurobiol       Date:  2019-08-17       Impact factor: 3.964

3.  Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy.

Authors:  R H Christie; B J Bacskai; W R Zipfel; R M Williams; S T Kajdasz; W W Webb; B T Hyman
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

4.  Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer's disease.

Authors:  Hisaaki Takahashi; Ivona Brasnjevic; Bart P F Rutten; Nicolien Van Der Kolk; Daniel P Perl; Constantin Bouras; Harry W M Steinbusch; Christoph Schmitz; Patrick R Hof; Dara L Dickstein
Journal:  Brain Struct Funct       Date:  2010-03-07       Impact factor: 3.270

5.  Bacopa monnieri prevents colchicine-induced dementia by anti-inflammatory action.

Authors:  Neetu Saini; Devinder Singh; Rajat Sandhir
Journal:  Metab Brain Dis       Date:  2019-01-02       Impact factor: 3.584

6.  Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Anne B Rocher; Athena Ching-Jung Wang; William G M Janssen; Tony Flores; Gissel M Perez; James Schmeidler; Dara L Dickstein; Patrick R Hof; Gregory A Elder
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

7.  Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance.

Authors:  Thierry Bussière; Frédérique Bard; Robin Barbour; Henry Grajeda; Terry Guido; Karen Khan; Dale Schenk; Dora Games; Peter Seubert; Manuel Buttini
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

8.  Abeta immunotherapy protects morphology and survival of adult-born neurons in doubly transgenic APP/PS1 mice.

Authors:  Barbara Biscaro; Olle Lindvall; Christoph Hock; Christine T Ekdahl; Roger M Nitsch
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

9.  Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status.

Authors:  Minna Groenning
Journal:  J Chem Biol       Date:  2009-08-20

10.  Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Abeta species in amyloid precursor protein transgenic mice.

Authors:  Irina Petrushina; Anahit Ghochikyan; Mikayel Mktrichyan; Gregory Mamikonyan; Nina Movsesyan; Hayk Davtyan; Archita Patel; Elizabeth Head; David H Cribbs; Michael G Agadjanyan
Journal:  J Neurosci       Date:  2007-11-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.